Tu J, Wang B, Wang X, Huo K, Hu W, Zhang R
Liver Res. 2025; 8(4):218-236.
PMID: 39958920
PMC: 11771281.
DOI: 10.1016/j.livres.2024.12.001.
Huang L, Wang Z, Lu J
Front Oncol. 2025; 14():1489725.
PMID: 39839797
PMC: 11746055.
DOI: 10.3389/fonc.2024.1489725.
Tian J, Pan S, Wang Y, Yu Y, Wang S, Shen Y
Biomedicines. 2025; 12(12.
PMID: 39767676
PMC: 11672884.
DOI: 10.3390/biomedicines12122769.
Ka-Wai Cheung J, Li K, Zhou L, To C, Lam T
Int J Mol Sci. 2024; 25(19).
PMID: 39408973
PMC: 11476992.
DOI: 10.3390/ijms251910644.
Wu H, Zhang G, Yang X
Mikrochim Acta. 2024; 191(9):565.
PMID: 39192061
DOI: 10.1007/s00604-024-06618-4.
Protein Kinase C Delta Is a Novel Biomarker for Hepatocellular Carcinoma.
Oikawa T, Yamada K, Tsubota A, Saeki C, Tago N, Nakagawa C
Gastro Hep Adv. 2024; 2(1):83-95.
PMID: 39130149
PMC: 11308090.
DOI: 10.1016/j.gastha.2022.07.020.
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications.
Chen K, Shuen T, Chow P
Br J Cancer. 2024; 131(3):420-429.
PMID: 38760445
PMC: 11300599.
DOI: 10.1038/s41416-024-02684-w.
Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma.
Dong B, Zhang H, Duan Y, Yao S, Chen Y, Zhang C
J Transl Med. 2024; 22(1):455.
PMID: 38741163
PMC: 11092049.
DOI: 10.1186/s12967-024-05203-w.
Establishing Neonate-Specific Prognostic Markers in Acute Liver Failure: Admission Alpha Fetoprotein and Novel Neonatal Acute Liver Failure Scores Predict Patient Outcomes.
Rolfes P, Sundaram S, Sokol R, Taylor S
J Pediatr. 2024; 272:114080.
PMID: 38692563
PMC: 11347118.
DOI: 10.1016/j.jpeds.2024.114080.
Combination of serum alpha-fetoprotein, PIVKA-Ⅱ and glypican-3 in diagnosis of hepatocellular carcinoma: a meta-analysis.
Song H, Wang J, Zhang H, Wu Y, Wang K, Wang X
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(1):131-139.
PMID: 38310085
PMC: 10945496.
DOI: 10.3724/zdxbyxb-2023-0483.
Chinese expert consensus statement on the clinical application of AFP/AFP-L3%/DCP using GALAD and GALAD-like algorithm in HCC.
Huang C, Xiao X, Zhou L, Chen F, Wang J, Hu X
J Clin Lab Anal. 2023; 37(23-24):e24990.
PMID: 38063322
PMC: 10756949.
DOI: 10.1002/jcla.24990.
Intelectin-1 is a novel prognostic biomarker for hepatocellular carcinoma.
Li J, Tao H, Yuan T, Huang Z, Zhang E
Medicine (Baltimore). 2023; 102(48):e36474.
PMID: 38050235
PMC: 10695524.
DOI: 10.1097/MD.0000000000036474.
The combination of a prolonged treatment time window and alpha-fetoprotein benefits the tumor response of hepatocellular carcinoma patients as evaluated by the imRECIST: a single-center, retrospective study.
Yin K, Li M, Liao R, Shi Z, Qiu J, Lan X
J Gastrointest Oncol. 2023; 14(2):932-942.
PMID: 37201094
PMC: 10186499.
DOI: 10.21037/jgo-23-167.
Vesicular Integral-Membrane Protein 36 Is Involved in the Selective Secretion of Fucosylated Proteins into Bile Duct-like Structures in HepG2 Cells.
Muranaka M, Takamatsu S, Ouchida T, Kanazawa Y, Kondo J, Nakagawa T
Int J Mol Sci. 2023; 24(8).
PMID: 37108200
PMC: 10138374.
DOI: 10.3390/ijms24087037.
Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression.
Yu M, Huang L, Zhang S, Jiang L, Jin Y, Gu M
Front Cell Infect Microbiol. 2023; 13:1082390.
PMID: 36761898
PMC: 9905438.
DOI: 10.3389/fcimb.2023.1082390.
Multiplexed smFRET Nucleic Acid Sensing Using DNA Nanotweezers.
Kaur A, Mahmoud R, Megalathan A, Pettit S, Dhakal S
Biosensors (Basel). 2023; 13(1).
PMID: 36671954
PMC: 9856376.
DOI: 10.3390/bios13010119.
Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Yang C, Wu X, Liu J, Wang H, Jiang Y, Wei Z
J Hepatocell Carcinoma. 2023; 10:43-55.
PMID: 36660412
PMC: 9844149.
DOI: 10.2147/JHC.S396433.
Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
Xiaochun H, Feixiong P, Shengsong O, Xiaojiao W, Yuju X, Yanhua L
Dis Markers. 2022; 2022:1739995.
PMID: 36212175
PMC: 9534708.
DOI: 10.1155/2022/1739995.
Older Age and High α-Fetoprotein Predict Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis-B-Related Cirrhotic Patients Receiving Long-Term Nucleos(t)ide Analogue Therapy.
Liu Y, Lin C, Weng C, Chang P, Chien C, Huang K
Diagnostics (Basel). 2022; 12(9).
PMID: 36140487
PMC: 9497657.
DOI: 10.3390/diagnostics12092085.
Oncofetal reprogramming in tumour development and progression.
Sharma A, Bleriot C, Currenti J, Ginhoux F
Nat Rev Cancer. 2022; 22(10):593-602.
PMID: 35999292
DOI: 10.1038/s41568-022-00497-8.
